Serveur d'exploration sur la microsimulation - Curation (PubMed)

Index « MedMesh.i » - entrée « Early Detection of Cancer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drugs, Generic < Early Detection of Cancer < Early Diagnosis  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000024 (2013) Sepideh Saadatmand [Pays-Bas] ; Madeleine M A. Tilanus-Linthorst ; Emiel J T. Rutgers ; Nicoline Hoogerbrugge ; Jan C. Oosterwijk ; Rob A E M. Tollenaar ; Maartje Hooning ; Claudette E. Loo ; Inge-Marie Obdeijn ; Eveline A M. Heijnsdijk ; Harry J. De KoningCost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
000035 (2013) E M Wever [Pays-Bas] ; E A M. Heijnsdijk ; G. Draisma ; C H Bangma ; M J Roobol ; F H Schröder ; H J De KoningTreatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors.
000057 (2013) Roman Gulati [États-Unis] ; John L. Gore ; Ruth EtzioniComparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.
000070 (2012) Amy B. Knudsen [États-Unis] ; Chin Hur ; G Scott Gazelle ; Deborah Schrag ; Elizabeth G. Mcfarland ; Karen M. KuntzRescreening of persons with a negative colonoscopy result: results from a microsimulation model.
000082 (2012) Pamela M. Mcmahon [États-Unis] ; Chung Yin Kong ; Bruce E. Johnson ; Milton C. Weinstein ; Jane C. Weeks ; Angela C. Tramontano ; Lauren E. Cipriano ; Colleen Bouzan ; G Scott GazelleChapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening.
000083 (2012) Eveline A M. Heijnsdijk [Pays-Bas] ; Elisabeth M. Wever ; Anssi Auvinen ; Jonas Hugosson ; Stefano Ciatto ; Vera Nelen ; Maciej Kwiatkowski ; Arnauld Villers ; Alvaro Páez ; Sue M. Moss ; Marco Zappa ; Teuvo L J. Tammela ; Tuukka M Kinen ; Sigrid Carlsson ; Ida J. Korfage ; Marie-Louise Essink-Bot ; Suzie J. Otto ; Gerrit Draisma ; Chris H. Bangma ; Monique J. Roobol ; Fritz H. Schröder ; Harry J. De KoningQuality-of-life effects of prostate-specific antigen screening.
000086 (2012) E M Wever [Pays-Bas] ; J. Hugosson ; E A M. Heijnsdijk ; C H Bangma ; G. Draisma ; H J De KoningTo be screened or not to be screened? Modeling the consequences of PSA screening for the individual.
000087 (2012) Charles W. Drescher [États-Unis] ; Sarah Hawley ; Jason D. Thorpe ; Simone Marticke ; Martin Mcintosh ; Sanjiv S. Gambhir ; Nicole UrbanImpact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screening.
000089 (2012) Esther W. De Bekker-Grob [Pays-Bas] ; Inge M C M. De Kok ; Johan Bulten ; Joost Van Rosmalen ; Judith E M. Vedder ; Marc Arbyn ; Paul J J M. Klinkhamer ; Albertus G. Siebers ; Marjolein Van BallegooijenLiquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis.
000092 (2012) Iris Lansdorp-Vogelaar [Pays-Bas] ; Karen M. Kuntz ; Amy B. Knudsen ; Marjolein Van Ballegooijen ; Ann G. Zauber ; Ahmedin JemalContribution of screening and survival differences to racial disparities in colorectal cancer rates.
000094 (2013) S Lucas Goede [Pays-Bas] ; Aafke H C. Van Roon ; Jacqueline C I Y. Reijerink ; Anneke J. Van Vuuren ; Iris Lansdorp-Vogelaar ; J Dik F. Habbema ; Ernst J. Kuipers ; Monique E. Van Leerdam ; Marjolein Van BallegooijenCost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening.
000101 (2012) Chung Y. Kong [États-Unis] ; Janie M. Lee ; Pamela M. Mcmahon ; Kathryn P. Lowry ; Zehra B. Omer ; Jonathan D. Eisenberg ; Pari V. Pandharipande ; G Scott GazelleUsing radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.
000106 (2012) Ulrike Haug [Allemagne] ; Amy B. Knudsen ; Karen M. KuntzHow should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis.
000114 (2012) J. Van Rosmalen [Pays-Bas] ; I M C M. De Kok ; M. Van BallegooijenCost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
000131 (2011) Janneke A. Wilschut [Pays-Bas] ; Lieke Hol ; Evelien Dekker ; Jan B. Jansen ; Monique E. Van Leerdam ; Iris Lansdorp-Vogelaar ; Ernst J. Kuipers ; J Dik F. Habbema ; Marjolein Van BallegooijenCost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening.
000135 (2011) John T. Schousboe [États-Unis] ; Karla Kerlikowske ; Andrew Loh ; Steven R. CummingsPersonalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
000150 (2011) Janneke A. Wilschut [Pays-Bas] ; Ewout W. Steyerberg ; Monique E. Van Leerdam ; Iris Lansdorp-Vogelaar ; J Dik F. Habbema ; Marjolein Van BallegooijenHow much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
000155 (2011) Laura J. Havrilesky [États-Unis] ; Gillian D. Sanders ; Shalini Kulasingam ; Junzo P. Chino ; Andrew Berchuck ; Jeffrey R. Marks ; Evan R. MyersDevelopment of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
000168 (2010) Carolyn M. Rutter [États-Unis] ; James E. SavarinoAn evidence-based microsimulation model for colorectal cancer: validation and application.
000219 (2009) Iris Lansdorp-Vogelaar [Pays-Bas] ; Marjolein Van Ballegooijen ; Rob Boer ; Ann Zauber ; J Dik F. HabbemaA novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials.
000220 (2009) Gerrit Draisma [Pays-Bas] ; Ruth Etzioni ; Alex Tsodikov ; Angela Mariotto ; Elisabeth Wever ; Roman Gulati ; Eric Feuer ; Harry De KoningLead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=MicroSimulV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Early Detection of Cancer" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Early Detection of Cancer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    MicroSimulV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Early Detection of Cancer
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sun Mar 10 17:35:57 2024. Site generation: Sun Mar 10 17:47:34 2024